JAYANTHI PERIASAMY: Open Payments
NPI 1912966573 · SOMERSET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,257 in 119 payments from 14 companies in 2025. Trend: 2023 $1,112 · 2024 $1,579 · 2025 $2,257
Food & beverage: $2,158Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $367 |
| Lundbeck LLC | 21 | $341 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $262 |
| Axsome Therapeutics, Inc. | 8 | $231 |
| Teva Pharmaceuticals USA, Inc. | 9 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $177 |
| Otsuka America Pharmaceutical, Inc. | 11 | $173 |
| Tris Pharma Inc | 10 | $163 |
| Janssen Pharmaceuticals, Inc | 5 | $94 |
| Vanda Pharmaceuticals Inc. | 5 | $85 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Auvelity, TRINTELLIX, Dyanavel XR, AUSTEDO XR, FANAPT.
Industry payments across NJ — which companies pay providers there.
